Dr. Reddy’s to participate in HSBC, Bank of America investor conferences
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
The US regulator conducted an inspection at the Amaliya manufacturing plant between April 20 and May 1, 2026
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
Subscribe To Our Newsletter & Stay Updated